DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,030.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA EV/EBITDA

-177.3%
Upside

As of 2025-07-08, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.0x - 14.0x 13.5x
Forward P/E multiples 22.9x - 28.4x 26.7x
Fair Price (34.01) - (19.89) (29.56)
Upside -189.0% - -152.0% -177.3%
38.22 USD
Stock Price
(29.56) USD
Fair Price

DRNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA